GLP-1 clinical trials in Louisiana: 14 recruiting now
25 sites in 10 Louisiana cities. Registry checked October 16, 2026.
Screening for a study can take weeks. Two cash programs to check.
No insurance needed.
- FoundSponsored$289 a monthcompounded semaglutideCheck price →Each plan shows a monthly cash price
- ShedSponsored$199 a month30% off first month with code Shed10compounded semaglutideCheck price →A health form first, then you choose your plan
Weight-loss studies (5)
Weight-loss study of orforglipron
Where: Lafayette
What: Tests whether a GLP-1 medicine from Lilly, orforglipron, can help people lose weight.
Free to join
Who can join: Children and teens 6 to 17 with obesity.
Call the site: 337-519-4742Study record on ClinicalTrials.gov
Velocity Clinical Research, Lafayette. 337-519-4742
Weight-loss study of orforglipron
Where: Lafayette
What: Tests whether a GLP-1 medicine from Lilly, orforglipron, can help people lose weight.
Free to join
Who can join: Children and teens 12 to 17 with obesity.
Study record on ClinicalTrials.gov
Velocity Clinical Research, Lafayette
Weight-loss study of cagrilintide
Where: Baton Rouge
What: Tests whether a study medicine from Novo Nordisk, cagrilintide, can help people lose weight.
Free to join
Who can join: Children and teens 8 to 18 who are overweight.
Study record on ClinicalTrials.gov
Pennington Biomed Res Ctr, Baton Rouge
Show 2 more studies
Weight-loss study of maridebart cafraglutide
Where: Baton Rouge
What: Tests whether a study medicine from Amgen, Maridebart Cafraglutide, can help people lose weight.
Free to join
Who can join: Adults 18+ with obesity or overweight, BMI 25+.
Study record on ClinicalTrials.gov
Pennington Biomedical Research Center, Baton Rouge
Weight-loss study of semaglutide
Where: Zachary
What: Tests whether a GLP-1 medicine from Novo Nordisk, semaglutide, can help people lose weight.
Free to join
Who can join: Adults 18+ who are overweight.
Study record on ClinicalTrials.gov
Southern Clin Research, Zachary
Other GLP-1 studies in Louisiana (9)
Fatty liver disease (MASLD) study of retatrutide
Where: Bastrop, Marrero, New Iberia and 2 more cities
What: Tests whether a GLP-1, GIP and glucagon medicine from Lilly, retatrutide, can help people reduce liver fat.
Free to join
Who can join: Adults 18+ with fatty liver disease (MASLD), BMI 25+.
Call the site: 318-281-6040Study record on ClinicalTrials.gov
Delta Research Partners of Bastrop, LLC, Bastrop. 318-281-6040
Tandem Clinical Research, Marrero. 504-934-8424
Care Access - New Iberia, New Iberia. 813-851-0135
Louisiana Research Center, Shreveport. 318-525-3233
Delta Research Partners of West Monroe, West Monroe
Fatty liver disease with liver scarring study of survodutide
Where: Bastrop, Marrero and Shreveport
What: Tests whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people reduce liver fat.
Free to join
Who can join: Adults 18+ with fatty liver disease (also called MASH or NASH) with liver scarring (fibrosis).
Call the site: 833-602-2368Study record on ClinicalTrials.gov
Delta Research Partners, LLC, Bastrop. 833-602-2368
Tandem Clinical Research, Marrero. 833-602-2368
Louisiana Research Center, LLC, Shreveport. 833-602-2368
Fatty liver disease (also called MASH or NASH) study of survodutide
Where: Bastrop, Marrero and Shreveport
What: Tests whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people reduce liver fat.
Free to join
Who can join: Adults 18+ with fatty liver disease (also called MASH or NASH), BMI 25+.
Call the site: 833-602-2368Study record on ClinicalTrials.gov
Delta Research Partners, LLC, Bastrop. 833-602-2368
Tandem Clinical Research, Marrero. 833-602-2368
Louisiana Research Center, LLC, Shreveport. 833-602-2368
Show 6 more studies
Ulcerative colitis study of tirzepatide
Where: New Iberia and Shreveport
What: Tests whether a GLP-1 and GIP medicine from Lilly, tirzepatide, can help people with ulcerative colitis calm gut inflammation.
Free to join
Who can join: Adults 18 to 70 with ulcerative colitis, BMI 27+.
Call the site: 813-851-0135Study record on ClinicalTrials.gov
Care Access - New Iberia, New Iberia. 813-851-0135
Louisiana Research Center, Shreveport. 318-525-3233
Crohn's disease study of tirzepatide
Where: New Iberia and Shreveport
What: Tests whether a GLP-1 and GIP medicine from Lilly, tirzepatide, can help people with Crohn's disease calm gut inflammation.
Free to join
Who can join: Adults 18 to 70 with Crohn's disease, BMI 27+.
Call the site: 813-851-0135Study record on ClinicalTrials.gov
Care Access - New Iberia, New Iberia. 813-851-0135
Louisiana Research Center, Shreveport. 318-525-3233
Prehypertension study of orforglipron
Where: Baton Rouge and Monroe
What: Tests whether a GLP-1 medicine from Lilly, orforglipron, can help people with prediabetes lose weight.
Free to join
Who can join: Adults 18+ who are overweight, BMI 25+.
Call the site: 225-763-2578Study record on ClinicalTrials.gov
Pennington Biomedical Research Center, Baton Rouge. 225-763-2578
IMA Clinical Research Monroe-Main, Monroe. 318-737-1098
Prediabetes study of semaglutide
Where: Baton Rouge
What: Tests whether a GLP-1 medicine, semaglutide, can help people with prediabetes lower blood sugar.
Free to join
Who can join: Adults 18 to 45, women only with prediabetes, BMI 25+.
Call the site: 225-924-8446Study record on ClinicalTrials.gov
Woman's Hospital, Baton Rouge. 225-924-8446
Osteoporosis study of tirzepatide
Where: Baton Rouge
What: Tests a GLP-1 and GIP medicine, tirzepatide, in adults with obesity.
Free to join
Who can join: Adults 18 to 50 with obesity.
Study record on ClinicalTrials.gov
Pennington Biomedical Research Center, Baton Rouge
Fatty liver disease (MASLD) study of tirzepatide
Where: Metairie
What: Tests whether a GLP-1 and GIP medicine, tirzepatide, can help people reduce liver fat.
Free to join
Who can join: Adults 18 to 75 with fatty liver disease (MASLD), BMI 30+.
Study record on ClinicalTrials.gov
Tandem Clinical Research, Plaza II, Metairie
Source: ClinicalTrials.gov, the federal registry, read October 16, 2026. Open a study's registry record before you call: it can close to new participants at any time. GLP Chart does not enroll anyone, is not paid for clinical-trial referrals and has no relationship with any sponsor or site on this page.
Clinical trials by state
Every state with a GLP-1 study recruiting today. 48 of them.
- Alabama (18)
- Arizona (22)
- Arkansas (5)
- California (53)
- Colorado (18)
- Connecticut (14)
- Delaware (1)
- District of Columbia (1)
- Florida (43)
- Georgia (23)
- Hawaii (6)
- Idaho (12)
- Illinois (30)
- Indiana (20)
- Iowa (10)
- Kansas (14)
- Kentucky (18)
- Louisiana (14)
- Maine (1)
- Maryland (25)
- Massachusetts (20)
- Michigan (21)
- Minnesota (19)
- Mississippi (7)
- Missouri (22)
- Montana (3)
- Nebraska (7)
- Nevada (11)
- New Hampshire (3)
- New Jersey (11)
- New Mexico (5)
- New York (30)
- North Carolina (31)
- North Dakota (5)
- Ohio (31)
- Oklahoma (12)
- Oregon (5)
- Pennsylvania (33)
- Rhode Island (5)
- South Carolina (25)
- South Dakota (2)
- Tennessee (27)
- Texas (56)
- Utah (14)
- Virginia (28)
- Washington (24)
- West Virginia (5)
- Wisconsin (7)